Analytical challenges translating mass spectrometry‐based phosphoproteomics from discovery to clinical applications

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Electrophoresis

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/elps.201400153PMID 24890697PMCID PMC4250476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphoproteomics in drug discovery.

  2014cited by this paper
• Rapid combinatorial ERLIC-SCX solid-phase extraction for in-depth phosphoproteome analysis.

  2013cited by this paper
• Is phosphoproteomics ready for clinical research?

  2013cited by this paper
• In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis.

  2013cited by this paper
• Enrichment specificity of micro and nano-sized titanium and zirconium dioxides particles in phosphopeptide mapping.

  2013cited by this paper
• Technologies and challenges in large‐scale phosphoproteomics

  2013cited by this paper
• Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit*

  2013cited by this paper
• Mass spectrometric protein maps for biomarker discovery and clinical research

  2013cited by this paper
• The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions*

  2013cited by this paper
• Identification of Direct Tyrosine Kinase Substrates Based on Protein Kinase Assay-Linked Phosphoproteomics*

  2013cited by this paper
• A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines.

  2013cited by this paper
• Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.

  2013cited by this paper
• Quantitative Measurement of Phosphoproteome Response to Osmotic Stress in Arabidopsis Based on Library-Assisted eXtracted Ion Chromatogram (LAXIC)*

  2013cited by this paper
• Quantitative phosphoproteomics identifies SnRK2 protein kinase substrates and reveals the effectors of abscisic acid action

  2013cited by this paper
• Analytical strategies for shotgun phosphoproteomics: status and prospects.

  2012cited by this paper
• Comparison of 4-plex to 8-plex iTRAQ Quantitative Measurements of Proteins in Human Plasma Samples

  2012cited by this paper
• Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance*

  2012cited by this paper
• Targeting cancer with small-molecular-weight kinase inhibitors.

  2012cited by this paper
• Advances in phosphopeptide enrichment techniques for phosphoproteomics

  2012cited by this paper
• The use of selected reaction monitoring in quantitative proteomics.

  2012cited by this paper
• Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates

  2012cited by this paper
• Sample preparation and analytical strategies for large-scale phosphoproteomics experiments.

  2012cited by this paper
• Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date

  2012cited by this paper
• Complementary Fe(3+)- and Ti(4+)-immobilized metal ion affinity chromatography for purification of acidic and basic phosphopeptides.

  2012cited by this paper
• Comparison of IMAC and MOAC for phosphopeptide enrichment by column chromatography.

  2012cited by this paper
• A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.

  2012cited by this paper
• Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

  2012cited by this paper
• Quantitative Phosphoproteomics Identifies Substrates and Functional Modules of Aurora and Polo-Like Kinase Activities in Mitotic Cells

  2011cited by this paper
• Tools for analyzing the phosphoproteome and other phosphorylated biomolecules: a review.

  2011cited by this paper
• Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches

  2011cited by this paper
• Mechanical Regulation of Glycogen Synthase Kinase 3β (GSK3β) in Mesenchymal Stem Cells Is Dependent on Akt Protein Serine 473 Phosphorylation via mTORC2 Protein*

  2011cited by this paper
• Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma*

  2011cited by this paper
• Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

  2011cited by this paper
• Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

  2011cited by this paper
• Overview: the maturing of proteomics in cardiovascular research.

  2011cited by this paper
• Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.

  2011cited by this paper
• Proteomic biomarker discovery: It's more than just mass spectrometry

  2011cited by this paper
• Zwitterionic hydrophilic interaction liquid chromatography (ZIC-HILIC and ZIC-cHILIC) provide high resolution separation and increase sensitivity in proteome analysis.

  2011cited by this paper
• Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling

  2011cited by this paper
• Proteomic and phosphoproteomic comparison of human ES and iPS cells

  2011cited by this paper
• Overview: The Maturing of Proteomics in Cardiovascular Research

  2011cited by this paper
• The human genome and drug discovery after a decade. Roads (still) not taken

  2011cited by this paper
• Too many roads not taken

  2011cited by this paper
• Comparison of ERLIC-TiO2, HILIC-TiO2, and SCX-TiO2 for global phosphoproteomics approaches.

  2011cited by this paper
• MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics

  2011cited by this paper
• Enhancing the Identification of Phosphopeptides from Putative Basophilic Kinase Substrates Using Ti (IV) Based IMAC Enrichment*

  2011cited by this paper
• Functionalized soluble nanopolymers for phosphoproteome analysis.

  2011cited by this paper
• On the development of plasma protein biomarkers.

  2011cited by this paper
• Personalized medicine in oncology: the future is now

  2010cited by this paper
• In-depth Analyses of Kinase-dependent Tyrosine Phosphoproteomes Based on Metal Ion-functionalized Soluble Nanopolymers*

  2010cited by this paper
• Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

  2010cited by this paper
• Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice.

  2010cited by this paper
• The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum.

  2010cited by this paper
• Protein kinase substrate profiling with a high-density peptide microarray.

  2010cited by this paper
• Enrichment and analysis of phosphopeptides under different experimental conditions using titanium dioxide affinity chromatography and mass spectrometry.

  2010cited by this paper
• Peptide Labeling with Isobaric Tags Yields Higher Identification Rates Using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap

  2010cited by this paper
• Phosphoproteomics in cancer

  2010cited by this paper
• Protein Microarrays: Novel Developments and Applications

  2010cited by this paper
• Reverse phase protein microarrays advance to use in clinical trials

  2010cited by this paper
• A comparative phosphoproteomic analysis of a human tumor metastasis model using a label‐free quantitative approach

  2010cited by this paper
• Super-SILAC mix for quantitative proteomics of human tumor tissue

  2010cited by this paper
• Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays

  2010cited by this paper
• Addressing Accuracy and Precision Issues in iTRAQ Quantitation*

  2010cited by this paper
• Probing the phosphoproteome of HeLa cells using nanocast metal oxide microspheres for phosphopeptide enrichment.

  2010cited by this paper
• Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics

  2009cited by this paper
• Supplementary Materials for Comparative Analysis Reveals Conserved Protein Phosphorylation Networks Implicated in Multiple Diseases

  2009cited by this paper
• Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics

  2009cited by this paper
• Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions

  2009cited by this paper
• Approaching clinical proteomics: current state and future fields of application in fluid proteomics

  2009cited by this paper
• Optimizing the performance of tin dioxide microspheres for phosphopeptide enrichment.

  2009cited by this paper
• An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers*

  2009cited by this paper
• Quantitative phospho-proteomics based on soluble nanopolymers.

  2009cited by this paper
• Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma*

  2009cited by this paper
• Tyrosine phosphorylation: thirty years and counting.

  2009cited by this paper
• Peptide microarrays for profiling of modification state-specific antibodies.

  2009cited by this paper
• iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly".

  2009cited by this paper
• Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests

  2009cited by this paper
• Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

  2009cited by this paper
• Targeting innate immunity protein kinase signalling in inflammation

  2009cited by this paper
• Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions

  2009cited by this paper
• Global and site-specific quantitative phosphoproteomics: principles and applications.

  2009cited by this paper
• Fully automatic separation and identification of phosphopeptides by continuous pH-gradient anion exchange online coupled with reversed-phase liquid chromatography mass spectrometry.

  2009cited by this paper
• Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates

  2008cited by this paper
• SIMAC (Sequential Elution from IMAC), a Phosphoproteomics Strategy for the Rapid Separation of Monophosphorylated from Multiply Phosphorylated Peptides*S

  2008cited by this paper
• Online automated in vivo zebrafish phosphoproteomics: from large-scale analysis down to a single embryo.

  2008cited by this paper
• Identification of c-Src Tyrosine Kinase Substrates Using Mass Spectrometry and Peptide Microarrays

  2008cited by this paper
• Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics.

  2008cited by this paper
• Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.

  2008cited by this paper
• Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry.

  2008cited by this paper
• Large‐scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography

  2008cited by this paper
• Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

  2008cited by this paper
• Niobium(V) oxide (Nb2O5): application to phosphoproteomics.

  2008cited by this paper
• A quantitative atlas of mitotic phosphorylation

  2008cited by this paper
• Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides.

  2008cited by this paper
• SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function.

  2008cited by this paper
• Signaling networks assembled by oncogenic EGFR and c-Met

  2008cited by this paper
• Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

  2008cited by this paper
• Hydrophilic Interaction Chromatography Reduces the Complexity of the Phosphoproteome and Improves Global Phosphopeptide Isolation and Detection*S

  2008cited by this paper

• Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery

  2026cites this paper
• Comprehensive Insights into Obesity and Type 2 Diabetes from Protein Network, Canonical Pathway, Phosphorylation and Antimicrobial Peptide Signatures of Human Serum

  2025cites this paper
• Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry

  2024cites this paper
• Decoding the secrets of small extracellular vesicle communications: exploring the inhibition of vesicle-associated pathways and interception strategies for cancer treatment.

  2024cites this paper
• Targeted Phosphoproteomics of Human Saliva Extracellular Vesicles via Multiple Reaction Monitoring Cubed (MRM3).

  2024cites this paper
• Comprehensive Overview of Bottom-Up Proteomics using Mass Spectrometry

  2023cites this paper
• Serum proteomic analysis of differentially expressed proteins and pathways involved in the mechanism of endemic osteoarthritis.

  2022cites this paper
• Molecularly Imprinted and Cladded Nanotags Enable Specific SERS Bioimaging of Tyrosine Phosphorylation.

  2022cites this paper
• Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation

  2022cites this paper
• Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets.

  2022cites this paper
• Hydrophilic polydopamine-derived mesoporous channels for loading Ti(IV) ions for salivary phosphoproteome research.

  2021cites this paper
• Facile synthesis of Ti4+-immobilized magnetic covalent organic frameworks for enhanced phosphopeptide enrichment.

  2021cites this paper
• Recent advances in top-down proteome sample processing ahead of MS analysis.

  2021cites this paper
• Beehive-inspired macroporous SERS probe for cancer detection through capturing and analyzing exosomes in plasma.

  2020cites this paper
• Identification of Prognostic Signature in Esophageal Cancer Based on Network Analysis

  2020cites this paper
• A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry

  2020cites this paper
• Automated Nanoflow Two-Dimensional Reversed-Phase Liquid Chromatography System Enables In-Depth Proteome and Phosphoproteome Profiling of Nanoscale Samples.

  2019cites this paper
• Blood-based protein biomarkers in breast cancer.

  2019cites this paper
• Proteomic and phosphoproteomic studies of monocyte recruitment and macrophage polarisation

  2019cites this paper
• Phosphoproteins Involved in the Inhibition of Apoptosis and in Cell Survival in the Leiomyoma

  2019cites this paper
• Epitope-imprinted mesoporous silica nanoparticles for specific recognition of tyrosine phosphorylation.

  2019cites this paper
• Highly Specific Enrichment of Multi-phosphopeptides by the Diphosphorylated Fructose-Modified Dual-Metal-Centered Zirconium-Organic Framework.

  2018cites this paper
• Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS.

  2017cites this paper
• Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.

  2017cites this paper
• Recent advances in phosphoproteomics and application to neurological diseases.

  2017cites this paper
• HONORING R . G . COOKS ' ELECTION TO THE NATIONAL ACADEMY

  2017cites this paper
• From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia.

  2017cites this paper
• Estimating the Efficiency of Phosphopeptide Identification by Tandem Mass Spectrometry

  2017cites this paper
• Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.

  2017cites this paper
• Exosomal proteins as potential markers of tumor diagnosis

  2017cites this paper
• Utilizing the Luminex Magnetic Bead-Based Suspension Array for Rapid Multiplexed Phosphoprotein Quantification.

  2017cites this paper
• Phosphoproteins in extracellular vesicles as candidate markers for breast cancer

  2017cites this paper
• Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases

  2016cites this paper
• Biomedical Analytics and Morphoproteomics: An Integrative Approach for Medical Decision Making for Recurrent or Refractory Cancers

  2016cites this paper
• Multidimensional electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) for quantitative analysis of the proteome and phosphoproteome in clinical and biomedical research.

  2015cites this paper
• Insight into protein variants/isoforms and post-translational modifications in a proteome

  2015cites this paper
• Mass spectrometry in leukemia research and treatment

  2015cites this paper
• Role of phosphoproteomics in the development of personalized cancer therapies

  2015cites this paper
• Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer

  2014cites this paper